Advanced search

Jakob Stausholm is Chief Strategy & Transformation Officer at Maersk Line A. In the past he was Group Chief Financial Officer of ISS An and Group Chief Financial Officer for ISS World Services A (a subsidiary of ISS A), Vice President-Asia Pacific Finance at Shell Plc, Chief Internal Auditor at Royal Dutch Shell Plc and Vice President-Finance at Shell Exploration & Production Co. (a subsidiary of Royal Dutch Shell Plc), Group Chief Financial Officer & Executive Director at A.P. Møller-Mærsk An and Chief Strategy, Finance & Transformation Officer at Maersk A. Jakob Stausholm received a graduate degree from the University of Copenhagen.

Currently, Jakob Gudbrand is Co-President & Co-Chief Executive Officer at GN Store Nord A. Mr. Gudbrand previously occupied the position of President-Chromatography & Mass Spectrometry at Thermo Fisher Scientific, Inc. and Chief Executive Officer of GN Hearing A. Mr. Gudbrand received an undergraduate degree from Technical University of Denmark.

Dr. Jakob Ley is a Member-Supervisory Board & Director-Research at Symrise AG.
He is on the Board of Directors at Symrise AG.
Dr. Ley was previously employed as a Head-Corporate Research by Symrise GmbH & Co. KG and a Head-Flavor Research by Haarmann & Reimer GmbH.
He received his doctorate degree from the University of Bonn.

Currently, Jakob Mörndal holds the position of Chief Executive Officer of Castellum AB. He is also on the board of Footway Group AB and Servistore AB. He previously held the position of Manager-Development at Klövern AB and Fixed Income Sales & Trading at Swedbank First Securities LLC. He received a graduate degree from Stockholm School of Economics.

Svein Jakob Liknes is currently the Chief Executive Officer at OKEA ASA since 2021.
Prior to this, he was the Chief Executive Officer at Aker Energy AS from 2019 to 2022.
He also worked as an Asset Manager at Skarv A and as a Senior Vice President-Operations at Aker BP ASA. Mr. Liknes completed his undergraduate degree from The University of Stavanger and Western Norway University of Applied Sciences.

Jakob currently works at BIO-LUTIONS International AG, as Director-Operations & Growth.

Jakob Ehrensvard was associated with Cypak AB, where he held the position of Chief Technology Officer from 2010 to 2013.
He is also the founder of Cypak AB, which was established in 1999.

Jakob Ackermann is a Director of Majestic Realty Co. He is Chairman of Commerce Construction Co. LP.
Mr. Ackermann received an undergraduate degree from Los Angeles Trade-Technical College.

Mr. Jakob Bluestone, CFA, is a Research Analyst at BNP Paribas SA. Mr. Bluestone was previously employed as an Analyst by Exane SA (United Kingdom), a Research Analyst by Credit Suisse Securities (Europe) Ltd., a Research Analyst by Merrill Lynch International, a Research Analyst by Merrill Lynch, Pierce, Fenner & Smith Ltd., and a Research Analyst by HSBC Bank Plc (Broker).

Jakob Baer served as Chief Executive Officer at KPMG Holding AG from 1992 to 2004.
He was a Director at Adecco Group AG from 2004 to 2012.
Baer was also a Counsel at Niederer Kraft Frey AG from 2004 to 2009.
He served as a Non-Executive Director at Allreal Holding AG from 2005 to 2014 and at Rieter Holding AG from 2006 to 2016.
Baer was an Independent Non-Executive Director at Schweizerische Rückversicherungs-Gesellschaft AG from 2011 to 2013 and at Swiss Re AG.
He was a Vice Chairman at Barry Callebaut AG from 2016 to 2019.
Baer holds a doctorate degree from the University of Bern, which he received in 1973.

Jakob Züger currently works at Schindler Elevators Ltd., as Chief Executive Officer.
Mr. Züger received his graduate degree in 1978 from Swiss Federal Institute of Technology.

Mr. Jakob C.
Loescher is a Financial Advisor & Team Lead at Savant Capital LLC (Illinois).
He is a team leader of a group of advisors that is responsible for managing approximately $1 billion in assets.
He has particular interest in aligning an individual’s values system with their financial goals and strives to empower clients with an understanding of finance that meets their desire and appetite for information.
He has been involved in the financial services industry since 2007.
He serves on the board of directors for Severson Dells Nature Center, Friends of the Coronado, and the Illinois Area YMCA, an endowment fund that benefits local YMCA staff and volunteers in Illinois and Indiana.
Mr. Loescher is a summa cum laude graduate of Northern Illinois University with a Bachelor of Science degree in Finance and a minor in History.
He is a Certified Financial Planner professional, a Chartered Financial Consultant, an Accredited Investment Fiduciary, a Chartered Retirement Planning Counselor, and a Chartered Retirement Plan Specialist.

Jakob Mikkelsen is currently the Chief Executive Officer & Director at Dissing Vordingborg ApS, Ejendomsselskabet Skovalléen 48 ApS, C.M.
Mikkelsen Ejendomsselskab ApS, C.M.
Mikkelsen ApS, Mr. Mikkelsen Holding ApS, and Mikkelsen Jakob Ejendomme ApS.
He is also the Chief Executive Officer at Allan C.
Hansen Aps.
Additionally, he serves as the Vice Chairman at Lollands Bank A and Chairman at Holberggård A.
He is the Deputy Chairman at Lollands Banks Ejendomme A and Director at Vorejendomme A and Poul Martin Møllersvej 6a K.
In the past, he was the Chief Executive Officer at Sadolin Farveland Nakskov ApS and served as an Independent Director at Vordingborg Bank A from 2008 to 2014.

Jakob Riis is currently the President & Chief Executive Officer at Falck A, the Chief Executive Officer & Director at Falck Danmark A, the Chief Executive Officer at Adelca ApS, and the Chairman at Falck Health Care Holding A.
He is also the Chairman of Falck Healthcare A, Copenhagen Institute of Interaction Design Aps, and a Non-Independent Director at H.
Lundbeck A.
Additionally, he serves as a Director at Dansk Erhverv and Response AS.
Previously, he held positions as a Director at Copenhagen Capacity, ALK-Abello A, and Novo Nordisk A, where he was the EVP & Head-North America Operations.
He also served as the President of Novo Nordisk, Inc. Dr. Riis obtained a graduate degree from the University of Copenhagen in 1993 and a doctorate degree from the same institution in 1998.

Jakob Benjamin Rudberg currently works at Coeli AB, as Vice President.

Mr. Jakob Eugster was Vice President at Converium Holding AG.

Jakob Rybak-Andersen is currently a Director at Radiocomp ApS and Frida Forsikring Agentur A.
He is also a Partner at VIA Equity A since 2006.
Previously, he held positions as Chairman at Duett AS and EnviDan A, and Director at GoIp International ApS, QAtor A, Conscia A, and Procom A.
Mr. Rybak-Andersen received his undergraduate and graduate degrees from Copenhagen Business School.

Jakob Berndt is associated with two companies, LemonAid Beverages GmbH and Tomorrow GmbH.
He is the founder of both companies.
At LemonAid Beverages GmbH, he held the title of Managing Director, and at Tomorrow GmbH, he held the title of Co-Managing Director.

Jakob Österberg is currently the Chief Executive Officer & Director at Slottsviken Fastighets AB and Lackarebäck Holding AB.
He is also an Independent Director at Link Prop Investment AB.
Previously, he served as the Chief Executive Officer at Lackarebäck.
Fastigheter AB from 2005 to 2013.
Mr. Österberg holds a graduate degree from the University of Gothenburg.

Jakob Ripp worked as Vice President-Business Development at StemRad Ltd.
before completing his undergraduate degree from Naval War College in 1996.
He then went on to complete his undergraduate degree and MBA from Ben-Gurion University of the Negev.

Mr. Thomas Jakob is a Managing Director at Kreissparkasse Biberach.
He is on the Board of Directors at Biotest AG.
He received his undergraduate degree from Universität Ulm.

Jakob Lage Hansen worked as a Strategist at Skandinaviska Enskilda Banken AB (Broker Denmark) from 2009 to 2013.

Peter Jakob has worked as a Senior Vice President-Product & Operations at PitchPoint Solutions, Inc. since 2003.

Jakob Brogaard is currently the Chairman at Finansiel Stabilitet and a Director at O.W.
Bunker & Trading AS.
He previously served as the Deputy Chairman at LR Realkredit A, Danske Bank A, and Roskilde Bank A.
He was also a Deputy Chairman at FS Finans A in 2012.
Additionally, he has held positions as a Director at Forsikringsselskabet Danica, Skadeforsikrings A and Danica Pension, Livsforsikringsaktieselskab.
He served as a Director at Ørsted A from 2007 to 2013 and at Wrist Marine Supplies A from 2012 to 2013.
He was a Director at Danica Liv III, Livsforsikringsaktieselskab and Danica Pension I, Livsforsikringsaktieselskab in 2010.
He also served as an Independent Board Member at OW Bunker A in 2013.

Prior to forming Stirling Square Capital Partners, Mr. Förschner was a Partner in the Private Equity Group of Compass Partners International Limited, having joined Compass in 2000 to establish the firm's direct presence in Germany.
In such capacity, Mr. Förschner set up Compass' operations in Frankfurt, and maintained primary origination and execution responsibilities in the German speaking markets of Austria, Germany and Switzerland.
Prior to joining Compass, Mr. Förschner was a Director with CVC Capital Partners, having joined this firm in 1991.
At CVC Capital Partners, Mr. Förschner was engaged in advising, structuring and financing leveraged and management buyouts, held board positions at several companies, and was instrumental in building CVC Capital Partners' German Advisory Board.
From 1989 to 1991 Mr. Förschner was Executive Trainee at Citibank NA, New York and Citibank AG, Frankfurt.
Mr. Förschner received a Degree in Economics from Johannes-Gutenberg-University Mainz, Germany, and is fluent in English and German.
Mr. Förschner currently serves on the Boards of Directors of IonBond and Schoeller Arca Systems.

Jakob Brink worked as an Analyst at ABG Sundal Collier ASA (Denmark), a Research Analyst at Svenska Handelsbanken AB (Broker Denmark), and as an Equity Analyst & Sector Coordinator at Nordea Bank Abp (Broker Denmark) from 2017 to 2024.

Jakob Knudsen is currently the Chief Executive Officer at ViroGates A, an Independent Director at ExpreS2ion Biotechnologies ApS, the Director of Mr. Knudsen Enkeltmandsvirksomhed, an Independent Director at Expres2ion Biotech Holding AB, a Director at Ingeniørsystem A, and a Non-Executive Director at P.V.
Fonden.
Previously, he held the position of Head-Business Development at ALK-Abello A from 1999 to 2008 and Chief Financial & Commercial Officer at Egalet Ltd.
from 2008 to 2011.
He holds an MBA from Imperial College London and a graduate degree from the University of Copenhagen.

Jakob Greger Gravdal is currently a Director at Norbit Aptomar AS.
Previously, he was a Director at Exensor Technology AB and a Research Analyst at Danske Bank A.
He also worked as an Investment Professional at Verdane Capital Advisors AS from 2011 to 2017.

Jakob Schlapbach worked as a Director at Cytos Biotechnology AG from 2011 to 2012.
He also worked as a Director at Lipideon Biotechnology AG and as the Chief Financial Officer at Ascom Holding AG and Cell Medica Switzerland AG.
Schlapbach earned an MBA from INSEAD in 1984 and an undergraduate degree from the University of Bern in 1979.

Jakob Korsgaard currently works at Odfjell Drilling AS, as Chief Operating Officer from 2023 and Odfjell Drilling Ltd., as Chief Operating Officer from 2023.

Jakob Reithmann is a Fund Manager at MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH since 2022.
Prior to this, he worked as a Portfolio Manager at Assenagon Asset Management SA (Germany) from 2018 to 2021.
He graduated from Erasmus University Rotterdam with a graduate degree in 2018 and from Ludwig-Maximilians-Universität München with an undergraduate degree in 2017.

Jakob Noe founded the Jakob NOE Nachfolger Stuttgarter Baugeräte Industrie GmbH in 1911.

Jakob Karstensen is currently working as an Associate at PKA AIP A.
Previously, he worked as an Analyst at Executive Capital Administration A from 2014 to 2016.

Jakob Loven is the founder of Syros Pharmaceuticals, Inc. (founded in 2013) and Relay Therapeutics, Inc. (founded in 2015).
He held the title of Senior Director-Business Development & Strategy at Relay Therapeutics, Inc. Dr. Loven's current job(s) include being a Director at Arvinas Operations, Inc., Arrakis Therapeutics, Inc., A2 Biotherapeutics, Inc., IconOVir Bio, Inc., Flare Therapeutics, Inc., Hexagon Bio, Inc., and Partner at Nextech Invest AG (since 2017).
Dr. Loven's former job(s) include being a Director at Turning Point Therapeutics, Inc. (2018-2019), Independent Director at Arvinas, Inc. (2018-2020), Director at Vividion Therapeutics, Inc., Independent Director at Kronos Bio, Inc., Director at Kinnate Biopharma, Inc. (2019-2020), Director at Autolus Therapeutics Plc, Independent Director at Boundless Bio, Inc., and Senior Associate at Third Rock Ventures LLC (2015-2016).
Dr. Loven obtained a doctorate degree from Karolinska Institutet and an undergraduate degree from the University of Anglia Ruskin.

Jakob Have is currently the Chief Executive Officer at Nordic Compound A, Nordic Compound Invest A, and Nordic Compound Management AS.
He is also a Director at Scandinavian Investment Group A, Orphazyme A, and Scandinavian Medical Solutions A.
In the past, he worked as a Director at Rovsing A, and as the Chief Financial Officer at Micro Matic A and SKAKO A.

Jakob Stott formerly worked at Quintet Private Bank (Europe) S.A., as Group Chief Executive Officer from 2020 to 2022 and Quintet Private Bank (Europe) SA (Broker), as Group Chief Executive Officer from 2020 to 2022.